Precision BioSciences, Inc. (Nasdaq: DTIL), a pioneering pre-clinical stage gene editing company based in Durham, North Carolina, has successfully raised $13 million to advance its innovative gene editing technologies. This funding will be instrumental in further developing the company's ARCUS genome editing platform, which harnesses sequence-specific DNA-cutting enzymes, also known as nucleases. These advanced tools enable not just precise gene knockouts, but also complex modifications such as gene insertion and repair. The successful funding round underscores investor confidence in Precision BioSciences' breakthrough potential to revolutionize the field of gene therapy through its versatile technology. The company aims to leverage this investment to propel its ongoing research and accelerate the development of targeted treatments for genetic disorders. As global interest in gene editing and its therapeutic applications continues to surge, Precision BioSciences is strategically positioned to make significant contributions to medical advancements that could improve or even save countless lives. The funding will support key initiatives, expanding pre-clinical studies and enhancing collaborations with academic institutions and industry partners to broaden the scope of ARCUS applications. Precision BioSciences remains committed to transforming the potential of gene editing into tangible solutions that address unmet medical needs. For more information about Precision BioSciences and its groundbreaking work in gene editing, visit www.precisionbiosciences.com.
Precision BioSciences Secures $13 Million in Funding to Advance Gene Editing Innovations
Recently funded 路 $13.0MBiotechnology
Get the full Precision BioSciences, Inc. company profile
Access contacts, investors, buying signals & more
Other recently funded companies
View all
Laihua Online
Wuhan Laihua Information and Technology is an Internet leading source of information on educational opportunities for students to study in other countries especially in China. Either prospect is planning to come to China or is already in China for education (self-support or scholarship based) he will probably need one of the ranges of services we provide from Education, Translation, Notarization of legal documents to Internships & Jobs or Medical Tourism etc. It is a comprehensive directory of study abroad programs, including summer study abroad, service learning, intensive language programs and more. Wuhan Laihua Information and Technology first set out to fill the information gap between students with a desire to travel abroad to study and companies offering international programs.
$68.0M Series d
today
NEW ID
NEW ID is the latest subsidiary company of NEW, which has started up since August 2019 for a new digital contents/platform business domain. We are responsible for expanding the contents produced and acquired by NEW into various markets and creating our digital capabilities through partnering with a-lister digital content creators and providers in Korea.
